# Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery

> **NCT04007094** · NA · TERMINATED · sponsor: **Ohio State University** · enrollment: 21 (actual)

## Conditions studied

- Degenerative Disc Disease
- Spinal Stenosis
- Spondylosis
- Spondylolisthesis

## Interventions

- **OTHER:** ViviGen Cellular Bone Matrix

## Key facts

- **NCT ID:** NCT04007094
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-12
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Primary Investigator left university. Site completing follow up assessments for previously enrolled subject only.
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04007094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04007094, "Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04007094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*